This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014
This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Loading statistic...
| Number of drugs no longer under development | |
|---|---|
| 1998 | 2 |
| 1999 | 4 |
| 2000 | 3 |
| 2001 | 4 |
| 2002 | 8 |
| 2003 | 4 |
| 2004 | 11 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 25 |
| 2008 | 15 |
| 2009 | 11 |
| 2010 | 14 |
| 2011 | 13 |
| 2012 | 11 |
| 2013 | 23 |
| 2014 | 6 |
© Statista 2018
More information
Other interesting statistics
+Total global pharmaceutical R&D spending 2008-2022
Research and development expenditure: U.S. pharmaceutical industry 1995-2015
+Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase
+Leading global contract research organizations based on revenue 2017
+Industry sectors - expenditure on research and development 2013-2015
+Research and development in European pharmaceutical industry by country 2015
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Clinical trials"
Statista for Your Company: The Research and Analysis Tool
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Unsuccessful developing brain cancer drugs in the U.S. 1998-2014
- Total R&D costs including costs of capital for select cancer drugs 2017
- Revenue as a part of R&D spending for select cancer drugs 2017
- Revenue since approval for select cancer drugs 2017
- Total R&D costs of select cancer drugs 2017
- Unsuccessful attempts and new drugs for cancer types 1998-2014
- Time from R&D start to approval of select cancer drugs 2017
- Average prices of Gleevec - selected countries 2013
- Net price index for cancer products in developed markets 2014
- Anti-cancer drugs estimated market size in South Korea 2014-2020
- Italy: oncological surgeons experiencing budgetary restraints 2018
- Italy: oncologists' behavior when facing budgetary restraints 2018
- Italy: oncologists' opinion about scarcity of resources to treat cancer patients 2018
- Cancer drugs on the world market 2010
- U.S. online shopping cart abandonment rate 2012-2015
- Concern over NHS provision of cancer drugs in the United Kingdom (UK) 2015, by age
- Seoul residents' urge to give up their pets 2016
- Italy: number of lung cancer cases by gender 2010-2015
- Route of referral for treatment of mesothelioma in England 2014
Popular Related Keywords
- success
- lung cancer
- abandonment
- cancer drugs
- Show more